A comparative study between use of paracetamol v/s diclofenac in post ceserean patients for appropriate pain relief

A randomized control trial to optimize post-ceserean analgesia regimen - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068542

Enrollment

400

Registered

2024-06-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics

Interventions

Intervention1: Paracetamol: Tab Paracetamol 500mg per oral on demand from post operative day 2 Control Intervention1: Diclofenac(50mg) and serratiopeptidase(10mg): tab diclofenac(50mg) and serratiopep

Eligibility

Inclusion criteria

Inclusion criteria: Women undergoing ceserean section with no other co-morbidities

Exclusion criteria

Exclusion criteria: Women with medical and surgical disorders, PROM, anemia, abdominal wall edema

Design outcomes

Primary

Measure	Time frame
To standardize post-ceserean analgesia regimenTimepoint: At baseline,12 weeks,24 weeks,36 weeks	—

Secondary

Measure	Time frame
To cut down on the extended use of NSAIDs in post-operative careTimepoint: 12 months	—

Countries

India

Contacts

Public ContactDr Rajasri G Yaliwal

BLDE(DU)Shri B M Patil Medical college, hospital and research centre.

ryaliwal@bldedu.ac.in9845152240

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026